🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1a/b multicenter, open-label, non-randomized, dose-escalati...
Status
Completed
Location
Palo Alto Medical Foundation
Start Date
2013-10
Trial ID
NCT01957735
Treatments Being Tested
The goal of this double-blind, placebo-controlled randomized clinical trial...
Status
Recruiting
Location
Yale School of Medicine
Start Date
2024-06-01
Trial ID
NCT06191965
Left ventricular remodeling can still occur after primary percutaneous coro...
Status
Completed
Location
Dr. Kariadi Central General Hospital
Start Date
2024-01-28
Trial ID
NCT06661018
Treatments Being Tested
The single-center, randomized, open-label, three-period crossover bioavaila...
Status
Completed
Location
MEDEDUS, Ljubljana, Slovenia
Start Date
2017-08-29
Trial ID
NCT03284814
Treatments Being Tested
The single-center, randomized, open-label, five-period crossover single-dos...
Status
Completed
Location
ADM, ambulanta družinske medicine, Ljubljana, Slovenia
Start Date
2021-02-28
Trial ID
NCT04780074
Treatments Being Tested
The randomized, open-label, three period crossover single-dose bioavailabil...
Status
Completed
Location
University of Primorska
Start Date
2022-03-09
Trial ID
NCT05272228
The goal of this clinical trial is to compare the relative bioavailability ...
Status
Completed
Location
Biofortis Clinical Research
Start Date
2026-05-18
Trial ID
NCT07530250
Treatments Being Tested
The randomized, open-label, two period crossover single-dose bioavailabilit...
Status
Completed
Location
University of Primorska, Faculty of Health Sciences
Start Date
2024-12-05
Trial ID
NCT06736366
Treatments Being Tested
The goal of this clinical trial is to learn if the AMBROSIA Bar helps preve...
Status
Recruiting
Location
Azienda Ospedaliera Universitaria Careggi
Start Date
2022-02-07
Trial ID
NCT07076329
Treatments Being Tested